Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies

Authors :: C Primas
Walter Reinisch
Joon Ho Lee
Gottfried Novacek
S Reinisch
S Kim
M Kutschera
S Lee
Diane R. Mould
Source :: Zeitschrift für Gastroenterologie.
Publication Year :: 2021
Publisher :: Georg Thieme Verlag KG, 2021.

Subjects :: Drug
biology
business.industry
media_common.quotation_subject
biology.protein
Medicine
Antibody
Pharmacology
business
Infliximab
medicine.drug
media_common

Full Text Access

Tools